Unlock the Potential of 4-Fluorophenibut HCl: A Deep Dive into its Properties and Applications
Explore the chemical intricacies and research applications of this key GABA analog for advanced scientific discovery.
Get a Quote & SampleProduct Core Value
4-Amino-3-(4-fluorophenyl)butyric acid hydrochloride
This compound is a synthetic molecule that acts as a GABA_B receptor agonist, offering significant potential in pharmaceutical research. Its ability to modulate neuronal excitability makes it a key area of interest for developing new treatments for neurological conditions.
- Explore the anxiolytic effects of GABA_B receptor agonists, a crucial area in understanding and treating anxiety disorders.
- Delve into the nootropic effects of GABA analogs, examining their impact on cognitive function and brain health.
- Understand the chemical synthesis of GABA analogs, crucial for developing novel pharmaceutical intermediates.
- Investigate its role in neuroscience studies, providing insights into synaptic mechanisms and neurotransmitter modulation.
Key Advantages
GABAergic Modulation Expertise
Leverage its function as a GABA_B receptor agonist to explore targeted therapeutic interventions in neurological conditions.
Anxiolytic & Nootropic Potential
Its properties suggest promise for developing treatments for anxiety and cognitive enhancement, vital for drug discovery.
Advanced Chemical Synthesis
Utilize this compound in advanced chemical synthesis of GABA analogs, paving the way for new pharmaceutical research.
Key Applications
Pharmaceutical Research
Investigate its potential applications in treating anxiety and epilepsy, crucial for pharmaceutical research.
Neuroscience Studies
Employ this compound in neuroscience studies to gain deeper insights into neurotransmitter modulation and synaptic mechanisms.
Analytical Chemistry
Use as a reference standard in analytical methods for assessing GABA-related compounds, supporting precision in research.
Drug Discovery Programs
Its unique properties make it a valuable asset in drug discovery initiatives targeting neurological pathways.